CLIENTIFY Trademark
Serial Number: 79338187 • Registration: 7088971
CLIENTIFY is a trademark filed by
CLIENTIFY, S.L.
on February 21, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Joe McKinney Muncy Muncy, Geissler, Olds & Lowe, P.C.
125 S. Royal Street
Alexandria
VA 22314
United States
Trademark Details
Filing Date
February 21, 2022
Registration Date
June 27, 2023
Published for Opposition
April 11, 2023
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 24, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 28, 2023 FICS
FINAL DISPOSITION PROCESSED
Sep 28, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 27, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 27, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 27, 2023 R.PR
NOTIFICATION PROCESSED BY IB
May 1, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 11, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 11, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 7, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 5, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 22, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 3, 2023 CNSA
REFUSAL PROCESSED BY IB
Feb 27, 2023 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 23, 2023 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 3, 2023 RFCS
REFUSAL PROCESSED BY MPU
Feb 3, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 10, 2022 RFCR
NON-FINAL ACTION WRITTEN
Dec 9, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 6, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
May 3, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 26, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 14, 2022 REPR
